Parkinson's disease is a neurogenerative disorder that affects predominately the dopamine-producing (dopaminergic) neurons in the brain. People suffering from it face problems in motor movement, ...
On Tuesday, former Packers football player, Brett Favre announced he suffers from Parkinson’s Disease. Parkinson’s Disease is a brain disorder that impacts ...
Bayer Ag BAYRY and its wholly owned subsidiary BlueRock Therapeutics LP announced positive 24-month data from an early-stage ...
A Parkinson’s Love Story” is told from the perspectives of the author as wife, mother, friend, perceptive memoirist and ...
Annovis Bio (NYSE: ANVS), a late-stage, clinical-drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s disease (“AD”) and Parkinson’s disease ...
Parkinson's disease a common but complex neurodegenerative disorder that affects 10 million people worldwide. Here are some ...
Researchers conducted a retrospective cohort study to compare the effects of SGLT-2 inhibitors and DPP-4 inhibitors on Parkinson disease risk among adults with T2D.
More than 20 years later, Alberts and a team of researchers have received a $3 million, five-year award from the National ...
Swansea City AFC Foundation is launching walking football sessions for those affected by Parkinson’s disease, thanks to ...
The 16th-annual Great Salt Lick auction raised $19,000 on Sept. 21, with proceeds going to Parkinson's disease research at ...
A neurologist who treats and studies Parkinson's has a personal connection to the disease: Her father-in-law, who played in ...
The following is a summary of “SGLT2 Inhibitor Use and Risk of Dementia and Parkinson’s Disease Among Patients With Type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback